Furthermore, in stroke mice, STAT6 activation in microglia and Mφs improved efferocytosis and modulated microglia/Mφ phenotype, accelerated inflammation resolution and ameliorated stroke outcomes [6]. The gene discussed is STAT6; the disease is stroke disorder.